Orchard Therapeutics plc American Depositary Shares
ORTX
ORTX was delisted on the 23rd of January, 2024.
83 hedge funds and large institutions have $546M invested in Orchard Therapeutics plc American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.
121% more capital invested
Capital invested by funds: $247M → $546M (+$299M)
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
27% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 22
8% more funds holding
Funds holding: 77 → 83 (+6)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
75% less call options, than puts
Call options by funds: $508K | Put options by funds: $2.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$47M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$30.7M |
| 3 |
CC
Casdin Capital
New York
|
+$22.8M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$22.8M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$25.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$8.64M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$4.82M |
| 4 |
Morgan Stanley
New York
|
-$3.94M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.28M |
ORTX Hedge Fund Activity: Q1 2021 in Review
83 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Orchard Therapeutics plc American Depositary Shares (ORTX) for Q1 2021, worth a combined $546M — up 121% from $247M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new ORTX positions and 14 closed out — a net gain of 6 holders — while 28 added to existing stakes and 22 trimmed.
The largest buyer was Artisan Partners, adding an estimated $47M. The largest seller was Fidelity Investments, cutting an estimated $25.8M.
- 83 institutional investors held Orchard Therapeutics plc American Depositary Shares (ORTX) as of Q1 2021, up from 77 in Q4 2020.
- Funds reported $546M of Orchard Therapeutics plc American Depositary Shares stock for Q1 2021, up 121% quarter-over-quarter.
- 20 funds opened new Orchard Therapeutics plc American Depositary Shares positions in Q1 2021 and 14 closed out, a net change of +6 holders.
- The largest Orchard Therapeutics plc American Depositary Shares buyer in Q1 2021 was Artisan Partners, an estimated $47M added.
- The largest Orchard Therapeutics plc American Depositary Shares seller in Q1 2021 was Fidelity Investments, an estimated $25.8M sold.
Based on aggregated 13F filings for Q1 2021.